Affiliation:
1. Sun Yat-sen University
Abstract
Abstract
This study was designed to investigate the analgesic effect of perineural injection of BoNT/A on neuropathic pain induced by sciatic nerve chronic constriction injury (CCI) and possible mechanisms. SD rats were randomly divided into Sham group, CCI group and BoNT/A group. Paw mechanical withdrawal threshold (pMWT) and paw thermal withdrawal latency (pTWL) of each group were detected at different time points after surgery. The expression of myelin markers, autophagy markers and NLRP3 inflammasome-related molecules in injured sciatic nerves were examined at 12 days after surgery. Moreover, C-fiber evoked potential in spinal dorsal horn was recorded. The expression of SNAP-25, neuroinflammation and synaptic plasticity in spinal dorsal horn of each group was examined. Then rats treated with BoNT/A were randomly divided into DMSO group and Wnt agonist group to further explore the regulatory effect of BoNT/A on Wnt pathway. We found that pMWT and pTWL of ipsilateral paw were significantly decreased in CCI group compared with Sham group, which could be improved by perineural injection of BoNT/A at days 7, 9 and 12 after surgery. The peripheral mechanisms of perineural injection of BoNT/A may be related to the protective effect on myelin sheath by inhibiting NLRP3 inflammasome and promoting autophagy flow, while the central mechanisms may be associated with inhibition of neuroinflammation and synaptic plasticity in spinal dorsal horn due to its ability to inhibit SNAP-25 and Wnt pathway. As a new route of administration, perineural injection of BoNT/A can relieve CCI induced neuropathic pain probably via both peripheral and central mechanisms.
Publisher
Research Square Platform LLC
Reference34 articles.
1. Nerve Entrapments;Jacobson L;Clin Plast Surg,2020
2. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis;Finnerup NB;Lancet Neurol,2015
3. Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial;Apalla Z;Clin J Pain,2013
4. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial;Yuan RY;Neurology,2009
5. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial;Wu CJ;Cephalalgia,2012